Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Wall Street Banks And Household Brands Report Earnings

Published 07/17/2017, 10:02 PM
Updated 07/09/2023, 06:31 AM

As expected, a plethora of earnings reports have hit the tape this morning, including more of the bigger Wall Street banks and other household brands. Put simply, results are mostly good but ultimately mixed thus far. Let’s try to slog through what we’ve found at this hour.

Goldman Sachs GS beat estimates on both top and bottom lines, but shares are selling off following this earnings report on drastically lower fixed income revenues. Earnings of $3.95 per share beat the $3.51 in the Zacks consensus estimate, on sales of $7.887 billion, well ahead of the $7.57 billion expected. But it was the 40% drop in Fixed Income, Commodities and Currencies (FICC, a staple of Goldman Sachs’ holdings) and the second quarter in a row of poor performance in this segment.

Bank of America BAC also topped estimates: 46 cents per share on $22.83 billion beat the 43 cents and $21.91 billion, respectively, in the Zacks consensus. An after-tax windfall of $103 million related to the sale of its non-consumer credit card business helped achieve the quarterly beat on the top line. This is at least the fifth quarter in a row of posting an earnings beat for the North Carolina-based bank major.

Healthcare product retailer Johnson & Johnson (NYSE:JNJ) JNJ beat earnings estimates by 4 cents per share to $1.83 in the quarter, though revenues of $18.84 billion missed the $18.90 billion expected. However, guidance for both sales and earnings for fiscal 2017 were revised upward within the earnings report, helping JNJ shares rise 2% immediately following the results.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Defense contractor giant Lockheed Martin LMT surpassed the Zacks consensus for both earnings and revenues: $3.23 per share beat the $3.10 anticipated, and quarterly sales of $12.69 billion beat the $12.46 billion expected. The company’s Aeronautics segment grew 19% year over year, helping boost Lockheed’s results in the quarter, and the shares are trading up in today’s pre-market.

Zacks Rank #2 (Buy)-rated healthcare provider United Health UNH topped earnings estimates for its Q2, on revenues that marginally surpassed our consensus. Earnings of $2.46 per share beat by 8 cents in the quarter, and sales of $50.1 billion was a smudge above the $49.97 billion expected. The company has raised its forecast for fiscal 2017, and this marks at least the fifth quarter in a row of an earnings beat. Shares are up modestly at this hour.



Bank of America Corporation (NYSE:BAC

Johnson & Johnson (JNJ): Free Stock Analysis Report

Lockheed Martin Corporation (NYSE:LMT

Goldman Sachs Group, Inc. (The) (NYSE:GS

UnitedHealth Group Incorporated (NYSE:UNH

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.